Earnings Call · Q2 FY2023·2023-08-06

Q2 23EPS +9.46%·Rev n/aQ1 23EPS -1.45%·Rev n/aQ4 22EPS +4.76%·Rev n/aQ3 22EPS -5.33%·Rev n/a⚠ consensus missing

Kymera Therapeutics, Inc. KYMR

Bruce Jacobs — Chief Financial Officer

Nello Mainolfi — President and Chief Executive Officer

Jared Gollob — Chief Medical Officer

+11.1%1d on move date+11.4% vs SPY3d−6.6%5d−7.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more KYMR calls or request research access.

More KYMR calls Browse calls Request research access